loadpatents
Patent applications and USPTO patent grants for Berinstein; Neil.The latest application filed is for "vaccines using high-dose cytokines".
Patent | Date |
---|---|
Vaccines Using High-Dose Cytokines App 20160151473 - Spaner; David E. ;   et al. | 2016-06-02 |
Method of Inducing And/Or Enhancing An Immune Response to Tumor Antigens App 20150352198 - Berinstein; Neil ;   et al. | 2015-12-10 |
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer Grant 8,946,174 - Berinstein , et al. February 3, 2 | 2015-02-03 |
Multi-antigen vectors of melanoma Grant 8,911,991 - Berinstein , et al. December 16, 2 | 2014-12-16 |
Monoclonal antibodies and uses thereof Grant 8,802,383 - Berinstein , et al. August 12, 2 | 2014-08-12 |
Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof App 20130216563 - Berinstein; Neil ;   et al. | 2013-08-22 |
Monoclonal antibodies and uses thereof Grant 8,361,706 - Berinstein , et al. January 29, 2 | 2013-01-29 |
Tumor Antigens for the Prevention and/or Treatment of Cancer App 20130011422 - Berinstein; Neil ;   et al. | 2013-01-10 |
Monoclonal Antibodies and Uses Thereof App 20120295275 - Berinstein; Neil ;   et al. | 2012-11-22 |
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof Grant 8,257,717 - Berinstein , et al. September 4, 2 | 2012-09-04 |
Tumor antigens for prevention and/or treatment of cancer Grant 8,207,314 - Berinstein , et al. June 26, 2 | 2012-06-26 |
Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens App 20110319480 - Berinstein; Neil ;   et al. | 2011-12-29 |
Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer App 20110311543 - Berinstein; Neil ;   et al. | 2011-12-22 |
Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof App 20110250234 - Berinstein; Neil ;   et al. | 2011-10-13 |
Tumor antigens Bfa5 for prevention and/or treatment of cancer Grant 8,021,664 - Berinstein , et al. September 20, 2 | 2011-09-20 |
Method of inducing and/or enhancing an immune response to tumor antigens Grant 8,017,590 - Berinstein , et al. September 13, 2 | 2011-09-13 |
Tumor Antigens Bfa4 And Bcy1 For Prevention And / Or Treatment Of Cancer App 20110117640 - Berinstein; Neil ;   et al. | 2011-05-19 |
Monoclonal Antibodies and Uses Thereof App 20110045502 - Berinstein; Neil ;   et al. | 2011-02-24 |
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof Grant 7,851,212 - Berinstein , et al. December 14, 2 | 2010-12-14 |
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer Grant 7,851,213 - Berinstein , et al. December 14, 2 | 2010-12-14 |
Tumor Antigen Bfy3 For Prevention And/or Treatment Of Cancer App 20100278848 - Berinstein; Neil ;   et al. | 2010-11-04 |
Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens App 20100260807 - Berinstein; Neil ;   et al. | 2010-10-14 |
Monoclonal antibodies and uses thereof Grant 7,790,857 - Berinstein , et al. September 7, 2 | 2010-09-07 |
Modified KSA and Uses Thereof App 20090156519 - Berinstein; Neil ;   et al. | 2009-06-18 |
Monoclonal antibodies and uses thereof App 20080280309 - Berinstein; Neil ;   et al. | 2008-11-13 |
Tumor Antigens Bfa5 For Prevention And/Or Treatment Of Cancer App 20080138365 - Berinstein; Neil ;   et al. | 2008-06-12 |
Multi-antigen vectors of melanoma App 20060127360 - Berinstein; Neil ;   et al. | 2006-06-15 |
Tumor antigen BFA5 for prevention and / or treatment of cancer App 20050112099 - Berinstein, Neil ;   et al. | 2005-05-26 |
Vaccines using high-dose cytokines App 20040223949 - Astsaturov, Igor ;   et al. | 2004-11-11 |
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer App 20040197912 - Berinstein, Neil ;   et al. | 2004-10-07 |
Immunogenic polypetides encoded by mage minigenes and uses thereof App 20040033234 - Berinstein, Neil ;   et al. | 2004-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.